Results 101 to 110 of about 151,581 (308)

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi   +5 more
wiley   +1 more source

STRATEGIC MANAGEMENT: INNOVATION AND TECHNOLOGY STRATEGY - THE ROLE OF ARTIFICIAL INTELLIGENCE IN STRATEGIC DECISION-MAKING [PDF]

open access: yesJournal of Bio-Based Marketing
This paper discusses innovation and technology strategies with a specific focus on the integration of Artificial Intelligence (AI) into corporate strategic planning.
Angèle Gohard
doaj  

Effective strategic management : the prospective approach

open access: yes, 1989
Tiré à part pages 45 à 55, 11 références bibliographiquesLa prospective recognizes that the future is the raison d'être of the present, that it is multiple and uncertain, and that it is a way for everyone to take control of their own future. This article
GODET, Michel
core  

Screening Routine Clinical Notes for Epilepsy Surgery Candidates Using Large Language Models

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Epilepsy surgery is severely underutilized despite proven efficacy, with substantial under‐referral of eligible patients in routine clinical practice. This study evaluated the potential role of large language models (LLMs) as decision‐support tools for screening unstructured clinical notes to identify epilepsy surgery candidates and ...
Uriel Fennig   +9 more
wiley   +1 more source

Elements of strategic technology management [PDF]

open access: yes, 2010
In an increasingly complex economic and social environment, high technology companies are facing accelerating technological development and global technology-based competition.
Sahlman, Kari
core   +1 more source

Involving Micro and Small Enterprises in the Energy Transition: Evidence from Poland

open access: yesEnergies
The energy transition is one of humanity’s most significant challenges. All micro, small, medium, and large enterprises will have to face it, and some are already making progress. This paper focuses on the involvement of the smallest actors in the energy
Tomasz Bernat   +3 more
doaj   +1 more source

Macrofoundation for Strategic Technology Management

open access: yes, 1995
Neoclassical mainstream economics has no perspective on strategic technology management issues. Market failure economics (externalities etc.)can be of some use to analyze problems of relevance in strategic management problems with technology as a part ...
Pedersen, Jørgen Lindgaard
core  

Evaluation of a Novel Electric Health Record Sidecar Application to Display Rheumatoid Arthritis Clinical Outcomes During Clinic Visits: Results of a Stepped‐Wedge Cluster Randomized Pragmatic Trial

open access: yesArthritis Care &Research, EarlyView.
Objective We developed a novel electronic health record sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk   +16 more
wiley   +1 more source

Management Strategies For Sustainable Growth In Asian Entrepreneurial Firms

open access: yesJournal of Asia Entrepreneurship and Sustainability
The role of strategic management practices in sound growth in Asian entrepreneurial firms. Based on cross-country data on the World Bank Enterprise Survey (2011-2020), the study analyses the relationship between innovation orientation, operational ...
Siva Prakash C S   +5 more
doaj   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy